Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014

Crit Care Med. 2016 Oct;44(10):1861-70. doi: 10.1097/CCM.0000000000001830.

Abstract

Objectives: The 2009-2010 influenza A (H1N1pdm09) pandemic caused substantial morbidity and mortality among young patients; however, mortality estimates have been confounded by regional differences in eligibility criteria and inclusion of selected populations. In 2013-2014, H1N1pdm09 became North America's dominant seasonal influenza strain. Our objective was to compare the baseline characteristics, resources, and treatments with outcomes among critically ill patients with influenza A (H1N1pdm09) in Mexican and Canadian hospitals in 2014 using consistent eligibility criteria.

Design: Observational study and a survey of available healthcare setting resources.

Setting: Twenty-one hospitals, 13 in Mexico and eight in Canada.

Patients: Critically ill patients with confirmed H1N1pdm09 during 2013-2014 influenza season.

Interventions: None.

Measurements and main results: The main outcome measures were 90-day mortality and independent predictors of mortality. Among 165 adult patients with H1N1pdm09-related critical illness between September 2013 and March 2014, mean age was 48.3 years, 64% were males, and nearly all influenza was community acquired. Patients were severely hypoxic (median PaO2-to-FIO2 ratio, 83 mm Hg), 97% received mechanical ventilation, with mean positive end-expiratory pressure of 14 cm H2O at the onset of critical illness and 26.7% received rescue oxygenation therapy with prone ventilation, extracorporeal life support, high-frequency oscillatory ventilation, or inhaled nitric oxide. At 90 days, mortality was 34.6% (13.9% in Canada vs 50.5% in Mexico, p < 0.0001). Independent predictors of mortality included lower presenting PaO2-to-FIO2 ratio (odds ratio, 0.89 per 10-point increase [95% CI, 0.80-0.99]), age (odds ratio, 1.49 per 10 yr increment [95% CI, 1.10-2.02]), and requiring critical care in Mexico (odds ratio, 7.76 [95% CI, 2.02-27.35]). ICUs in Canada generally had more beds, ventilators, healthcare personnel, and rescue oxygenation therapies.

Conclusions: Influenza A (H1N1pdm09)-related critical illness still predominantly affects relatively young to middle-aged patients and is associated with severe hypoxemic respiratory failure. The local critical care system and available resources may be influential determinants of patient outcome.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adrenal Cortex Hormones / economics
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aged
  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use
  • Canada / epidemiology
  • Critical Illness / epidemiology
  • Critical Illness / therapy*
  • Extracorporeal Membrane Oxygenation / economics
  • Extracorporeal Membrane Oxygenation / methods
  • Female
  • Health Expenditures
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza, Human / economics
  • Influenza, Human / epidemiology
  • Influenza, Human / physiopathology*
  • Influenza, Human / therapy*
  • Intensive Care Units / statistics & numerical data*
  • Male
  • Mexico / epidemiology
  • Middle Aged
  • Respiration, Artificial / economics
  • Respiration, Artificial / methods
  • Respiratory Insufficiency / physiopathology
  • Respiratory Insufficiency / therapy

Substances

  • Adrenal Cortex Hormones
  • Antiviral Agents